Clinical Trials · NCT03856632
Liraglutide Effect in Atrial Fibrillation
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- University of Miami
- Enrollment
- 60
- Start date
- Mar 2019
- Locations
- 1 site, United States
- Primary endpoint
- Change in size of Left Atrial Epicardial Adipose Tissue (LAEAT)